Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients.

Saitta C, Raffa G, Alibrandi A, Brancatelli S, Lombardo D, Tripodi G, Raimondo G, Pollicino T.

Medicine (Baltimore). 2017 Jun;96(26):e7266. doi: 10.1097/MD.0000000000007266.

2.

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.

Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Klöters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W.

Oncotarget. 2017 Jul 11;8(28):46234-46248. doi: 10.18632/oncotarget.17598.

3.

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM, Han SB, Saab S.

J Clin Transl Hepatol. 2017 Mar 28;5(1):43-49. doi: 10.14218/JCTH.2016.00057. Epub 2017 Mar 8.

4.

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.

Park SJ, Jang JY, Jeong SW, Cho YK, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Park S, Bang HI.

Medicine (Baltimore). 2017 Mar;96(11):e5811. doi: 10.1097/MD.0000000000005811.

5.

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma.

Zhang Y, Li T, Qiu Y, Zhang T, Guo P, Ma X, Wei Q, Han L.

Medicine (Baltimore). 2017 Jan;96(2):e5642. doi: 10.1097/MD.0000000000005642.

6.

A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index.

Zhang A, Skog S, Wang S, Ke Y, Zhang Y, Li K, He E, Li N.

Sci Rep. 2016 Aug 16;6:31132. doi: 10.1038/srep31132.

7.

Risk prediction models for hepatocellular carcinoma in different populations.

Ma X, Yang Y, Tu H, Gao J, Tan YT, Zheng JL, Bray F, Xiang YB.

Chin J Cancer Res. 2016 Apr;28(2):150-60. doi: 10.21147/j.issn.1000-9604.2016.02.02.

8.

Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma.

Hayashi A, Shibahara J, Misumi K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M.

PLoS One. 2016 May 19;11(5):e0155744. doi: 10.1371/journal.pone.0155744. eCollection 2016.

9.

Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery.

Feng X, Song P, Bie P, Jiang P, Ma K, Li X, Wang S, Wang Z, Tang W, Zheng S.

Med Sci Monit. 2016 May 17;22:1663-72.

10.

A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma.

De J, Shen Y, Qin J, Feng L, Wang Y, Yang L.

Medicine (Baltimore). 2016 Apr;95(17):e3448. doi: 10.1097/MD.0000000000003448. Review.

11.

An update of biochemical markers of hepatocellular carcinoma.

AlSalloom AA.

Int J Health Sci (Qassim). 2016 Jan;10(1):121-36. Review.

12.

Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.

Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C.

PLoS One. 2016 Mar 17;11(3):e0151069. doi: 10.1371/journal.pone.0151069. eCollection 2016.

13.

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma.

Hayes CN, Chayama K.

Int J Mol Sci. 2016 Feb 24;17(3):280. doi: 10.3390/ijms17030280. Review.

14.

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W.

World J Gastroenterol. 2016 Jan 7;22(1):262-74. doi: 10.3748/wjg.v22.i1.262. Review.

15.

Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study.

Ette AI, Ndububa DA, Adekanle O, Ekrikpo U.

BMC Gastroenterol. 2015 Sep 4;15:113. doi: 10.1186/s12876-015-0344-9.

16.

Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.

Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK.

World J Gastroenterol. 2015 Apr 7;21(13):3928-35. doi: 10.3748/wjg.v21.i13.3928.

17.

Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.

Zakhary NI, Khodeer SM, Shafik HE, Abdel Malak CA.

J Adv Res. 2013 Nov;4(6):539-46. doi: 10.1016/j.jare.2012.10.004. Epub 2013 Jan 11.

18.

Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

Reichl P, Fang M, Starlinger P, Staufer K, Nenutil R, Muller P, Greplova K, Valik D, Dooley S, Brostjan C, Gruenberger T, Shen J, Man K, Trauner M, Yu J, Gao CF, Mikulits W.

Int J Cancer. 2015 Jul 15;137(2):385-394. doi: 10.1002/ijc.29394. Epub 2015 Jan 13.

19.

Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.

Zhu R, Yang J, Xu L, Dai W, Wang F, Shen M, Zhang Y, Zhang H, Chen K, Cheng P, Wang C, Zheng Y, Li J, Lu J, Zhou Y, Wu D, Guo C.

Gastroenterol Res Pract. 2014;2014:529314. doi: 10.1155/2014/529314. Epub 2014 Aug 6. Review.

20.

Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.

Wu CS, Lee TY, Chou RH, Yen CJ, Huang WC, Wu CY, Yu YL.

PLoS One. 2014 Jun 13;9(6):e99959. doi: 10.1371/journal.pone.0099959. eCollection 2014.

Supplemental Content

Support Center